Castillo A, Islam MT, Prieto MC, Majid DS. Tumor necrosis factor-␣ receptor type 1, not type 2, mediates its acute responses in the kidney. Am J Physiol Renal Physiol 302: F1650 -F1657, 2012. First published March 28, 2012 doi:10.1152/ajprenal.00426.2011.-Acute administration of tumor necrosis factor-␣ (TNF-␣) resulted in decreases in renal blood flow (RBF) and glomerular filtration rate (GFR) but induced diuretic and natriuretic responses in mice. To define the receptor subtypes involved in these renal responses, experiments were conducted to assess the responses to human recombinant TNF-␣ (0.3 ng·min Ϫ1 ·g body wt Ϫ1 iv infusion for 75 min) in gene knockout (KO) mice for TNF-␣ receptor type 1 (TNF␣R1 KO, n ϭ 5) or type 2 (TNF␣R2 KO, n ϭ 6), and the results were compared with those obtained in corresponding wild-type [WT (C57BL/6), n ϭ 6] mice. Basal levels of RBF (PAH clearance) and GFR (inulin clearance) were similar in TNF␣R1 KO, but were lower in TNF␣R2 KO, than WT mice. TNF-␣ infusion in WT mice decreased RBF and GFR but caused a natriuretic response, as reported previously. In TNF␣R1 KO mice, TNF-␣ infusion failed to cause such vasoconstrictor or natriuretic responses; rather, there was an increase in RBF and a decrease in renal vascular resistance. Similar responses were also observed with infusion of murine recombinant TNF-␣ in TNF␣R1 KO mice (n ϭ 5). However, TNF-␣ infusion in TNF␣R2 KO mice caused changes in renal parameters qualitatively similar to those observed in WT mice. Immunohistochemical analysis in kidney slices from WT mice demonstrated that while both receptor types were generally located in the renal vascular and tubular cells, only TNF␣R1 was located in vascular smooth muscle cells. There was an increase in TNF␣R1 immunoreactivity in TNF␣R2 KO mice, and vice versa, compared with WT mice. Collectively, these functional and immunohistological findings in the present study demonstrate that the activation of TNF␣R1, not TNF␣R2, is mainly involved in mediating the acute renal vasoconstrictor and natriuretic actions of TNF-␣.
renal hemodynamics; sodium excretion TUMOR NECROSIS FACTOR (TNF)-␣, a proinflammatory cytokine first reported by Carswell et al. (6) in 1975, was originally assigned roles in inflammation or in tumor rejection. It is now well recognized that TNF-␣ belongs to a family of soluble and cell-bound cytokines that have a wide range of functions, such as inflammation, lymphoid development, and apoptosis (12, 37) . TNF-␣ is produced predominantly by white blood cells (monocytes and macrophages); however, it can be generated by endothelial cells, as well as tubular epithelial and mesangial cells in the kidney, particularly upon inflammation and tissue injury (3, 9, 31) . TNF-␣ has been reported to exerts its cytokine signaling function through two different TNF-␣ receptors, TNF-␣ receptor type 1 (TNF␣R1, p55) and TNF-␣ receptor type 2 (TNF␣R2, p75) (4, 27) . However, the role of two distinct TNF-␣ receptors in mediating this cytokine's function has not been clearly defined. Generally, it is considered that TNF␣R1 mediates the cytotoxic effects of TNF-␣, whereas signaling through TNF␣R2 is mostly implied in protective effects of TNF-␣ (12, 35) .
Renal injury induced by ANG II is mediated by a range of cytokines, including TNF-␣. Inhibition of angiotensin-converting enzyme, or AT 1 receptor, inhibition has been shown to attenuate tubulointerstitial injury and reduce expression of cytokines and matrix proteins (5, 31) . ANG II-induced hypertension is characterized by the proliferation and infiltration of monocytes in the kidney (20) and increased production of proinflammatory cytokine TNF-␣ by T lymphocytes (18) . ANG II increases TNF-␣ production in mesangial, as well as renal epithelial, cells (13, 19, 21) . It has been demonstrated that the hypertensive response to chronic ANG II infusion is markedly attenuated in TNF-␣ knockout (KO) mice (33) . Renal vasoconstrictor response to acute ANG II infusion is also attenuated in TNF-␣ KO mice (22) . A relationship between the renin-angiotensin-aldosterone system and the production of a proinflammatory cytokine, TNF-␣, in regulating cardiovascular and renal function is increasingly evident from findings in many recent studies (10, 11, 14, 15) . These pathophysiological roles of TNF-␣ in the kidney emphasize the importance of investigating the direct effects of TNF-␣ on renal hemodynamics and excretory function.
We reported previously (32) that acute administration of human recombinant TNF-␣ in the mouse caused a dosedependent reduction in renal blood flow (RBF), as well as increases in urine flow (V) and sodium excretion (U Na V). Scavenging superoxide (O 2 Ϫ ) prevented TNF-␣-induced renal vasoconstrictor action, but not its natriuretic action, which was also not prevented by blocking nitric oxide (NO) production (32) . Further experiments demonstrated that the natriuretic response to TNF-␣ was abolished in mice pretreated with amiloride and bendroflumethiazide, suggesting that TNF-␣ exerts an inhibitory action on distal tubular sodium transport to induce such a response (29) . These diverse vascular and tubular effects of TNF in the kidney may be due to the presence of different receptors in these regions in the kidney. Immunohistochemical analysis of TNF receptors in human kidney samples (1) indicates that TNF␣R1 is predominantly present in renal vessels and glomeruli, while TNF␣R2 is mainly expressed in renal tubules. However, the specific roles of these receptors in the renal vascular and tubular actions of TNF-␣ have not been clearly defined.
In the present study, we aim to delineate these receptor actions in regulating renal hemodynamic and excretory function by evaluating the renal responses to acute administration of TNF-␣ in KO mice that are lacking TNF␣R1, as well as TNF␣R2, and comparing the responses with those in wild-type [WT (C57BL/6)] mice.
METHODS
All the experimental procedures were approved by and performed in accordance with the guidelines and practices established by the Tulane University Animal Care and Use Committee.
Groups of TNF␣R1 KO and TNF␣R2 KO, as well as WT mice (9 -10 wk old, ϳ25 g body wt) were purchased from Jackson Laboratories (Bar Harbor, ME). The mice were housed in a temperatureand light-controlled room in the Tulane Vivarium and allowed free access to standard diet (Ralston-Purina, St. Louis, MO) and tap water for Ն3 days before acute renal clearance studies were performed under anesthesia. On the day of experiments, the animals were anesthetized with thiobutabarbital sodium (100 mg/kg ip; Inactin, Sigma, St. Louis, MO), and the renal clearance studies were performed as described previously (32) . The mice were placed on a servo-controlled surgical table that maintained body temperature at 37°C, and a tracheostomy was performed. The animals were allowed to breathe air enriched with O 2: the exterior end of the tracheal cannula was placed inside a small plastic chamber into which humidified 95% O2-5% CO2 was continuously passed. The right carotid artery was cannulated with polyethylene (PE-10) tubing connected to a pressure transducer (AcqKnowledge data acquisition system, Biopac) for continuous recording of mean arterial pressure (MAP) and heart rate. The right jugular vein was catheterized with PE-10 tubing for fluid infusion at a rate of 3 l/min with the help of an infusion pump (CMA). During surgery, an isotonic saline solution containing 6% albumin (bovine serum; Calbiochem, La Jolla, CA) was infused. The bladder was catheterized with PE-90 tubing via a suprapubic incision for urine collection. After surgery, the infusion fluid was replaced with isotonic saline solution containing 1% albumin, 7.5% inulin (Inutest, Laevosan, Linz/Donau, Austria), and 1.5% PAH (Merck Sharpe & Dohme, West Point, PA), which was also used as a vehicle for TNF-␣ solution.
Experimental protocol. First, responses to a single dose (0.3 ng·g Ϫ1 ·min Ϫ1 iv) of human recombinant TNF-␣ (Invitrogen-Biosource) were assessed. This single dose was selected, as it was reported in our earlier study (32) describing the dose-response curve with TNF-␣ that this dose resulted in renal vasoconstriction, as well as natriuresis, without an appreciable change in systemic arterial pressure in WT mice. Responses to this single-dose infusion of TNF-␣ were assessed in control WT, as well as TNF␣R1 KO and TNF␣R2 KO, mice. The basic protocol with infusion of TNF-␣ in all the experiments in mice was as follows. After a 60-min equilibration period following completion of surgical procedures, two consecutive 30-min control urine collections (basal period) were performed. An arterial blood sample (100 l) was taken for measurements of basal hematocrit and plasma PAH, inulin, and sodium/potassium concentrations. Then an infusion of TNF-␣ was started at a rate of 0.3 ng·g Ϫ1 ·min Ϫ1 and continued until the end of the experiment. At 15 min after the initiation of TNF-␣ infusion (stabilization period), another two 30-min urine clearance collections were performed (treatment period). After the final collection period, another arterial blood sample (100 l) was taken for measurements of hematocrit, plasma PAH, inulin, and sodium/potassium concentrations. To evaluate the species specificity for the action of human TNF-␣ on TNF␣R2, as suggested earlier in an in vitro study (28) , we also examined the responses to murine recombinant TNF-␣ (Invitrogen-Biosource) in an additional group of TNF␣R1 KO mice. At the end of the experiment, the animals were euthanized with a high dose of anesthetic, and the kidneys were removed and weighed.
Immunohistochemical studies and semiquantitative analysis of TNF-␣ receptor protein expression in renal tissue. To determine the renal localization and distribution of the TNF-␣ receptors, WT, as well as KO, mice were euthanized, and the kidneys were isolated.
After decapsulation, one of the kidneys was cross sectioned and fixed in zinc-saturated formalin for immunohistochemical studies. Kidneys were embedded in paraffin blocks, sectioned (5 m), and mounted onto slides with Vectabond (Vector Laboratories, Burlingame, CA). Serial kidney sections were immunostained by the immunoperoxidase technique with modifications as described previously (30) . After dewaxing in xylene, the kidney sections were rehydrated in series with 100%, 95%, and 70% alcohol and treated with methanol and 0.3% H 2O2 for 30 min to block peroxidase activity. Then kidney sections were washed and sequentially incubated with 1) normal blocking rabbit serum for 30 min, 2) primary antibodies [rabbit polyclonal anti-TNF receptor 1 antibody (catalog no. ab19139, Abcam, Cambridge, MA) and rabbit monoclonal anti-TNF receptor 2 antibody (catalog no. 3605-1, Epitomics, Burlingame, CA)] diluted in normal blocking serum (Vector Laboratories) at 1:1,000 and 1:200 for TNF␣R1 and TNF␣R2, respectively, overnight at 4°C, 3) secondary antibody [biotin-conjugated rabbit anti-mouse IgG (Vector Laboratories)] for 30 min, and 4) avidin DH (biotinylated horseradish peroxidase H complex) using the ABC Elite Vectastain kit (Vector Laboratories) for 30 min. Peroxidase activity was visualized with 0.1% 3,3=-diaminobenzidine tetrahydrochloride (DAB substrate kit for peroxidase, catalog no. SK-4100, Vector Laboratories). The slides were counterstained with hematoxylin (VWR International, West Chester, PA) and mounted using aqueous mounting medium (Triangle Biomedical Sciences, Durham, NC), and coverslips were applied. Specific immunoreactivity was quantified in 20 different microscopic fields per tissue section per animal with use of a Nikon Eclipse 50i microscope, a ϫ40 objective, and an integrated digital camera system for image processing. The intensity of TNF␣R1 and TNF␣R2 immunoreactivity in all kidney sections was analyzed using NIS Elements Software AR (version 3.0 for Windows; Nikon), which allowed a computerized determination of the area of positive staining (m) and the intensity of immunoreactivity (sum of density of positive tubules in an analyzed area). The results are expressed in arbitrary units of the relative intensity and normalized to the mean values of specific immunostaining observed in the WT mice.
Calculation and statistical analysis. V was measured gravimetrically. Blood and urine samples collected during systemic experiments were analyzed for inulin, PAH, and sodium/potassium concentrations, as reported elsewhere (32) . Inulin and PAH concentrations were determined by spectrophotometry, and sodium/potassium concentrations were determined by flame photometry. Inulin clearance is considered glomerular filtration rate (GFR), and PAH clearance is considered renal plasma flow (RPF). RBF is calculated from RPF and hematocrit. The concentration of sodium in urine and blood was used to calculate U NaV and fractional excretion of sodium (FENa), respectively. Renal vascular resistance (RVR) is calculated by dividing mean systemic arterial pressure by RBF. The mean of the values obtained during the first two control collection periods was considered the "basal value," while the mean of the values collected during the two collection periods during TNF-␣ infusion was taken as the "treatment value." The differences in the values between the basal and treatment periods are considered the responses to TNF-␣ treatment. All values were normalized per gram of kidney weight. Results are expressed as means Ϯ SE. Statistical differences between basal and treatment values in the same set of experiments were analyzed by paired Student's t-test. Data among the different groups of animals were compared by unpaired Student's t-test. Differences are considered significant at P Ͻ 0.05.
RESULTS

Basal levels of renal hemodynamic and excretory function in TNF-␣ receptor gene KO mice.
The basal values of MAP, as well as renal hemodynamic and excretory function parameters, in these anesthetized TNF␣R1 KO, TNF␣R2 KO, and WT mice are summarized in Table 1 . The basal value of MAP was significantly lower in TNF␣R1 KO than WT mice. However, other renal hemodynamic parameters (RBF, RVR, and GFR) were not statistically different between WT and TNF␣R1 KO mice (Table 1) . On the other hand, V was slightly lower in TNF␣R1 KO than WT mice, which could be due to lower MAP in TNF␣R1 KO mice. Similarly, U Na V and FE Na were also lower in TNF␣R1 KO than WT mice, but the difference did not reach statistical significance, possibly because of wide variability in the basal values. The basal MAP value in TNF␣R2 KO mice was not statistically different from that in WT mice. However, the basal values of renal hemodynamic parameters (RBF, RVR, and GFR) were significantly lower in TNF␣R2 KO than WT mice. Despite the lower values for the renal parameters in TNF␣R2 KO than WT mice, the basal values for the excretory parameters [V, U Na V, FE Na , and urinary potassium excretion (U K V)] were similar in both strains of mice. RVR was higher, while RBF and GFR were lower, in TNF␣R2 KO than TNF␣R1 KO mice. V was also higher in TNF␣R2 KO than TNF␣R1 KO mice.
Renal hemodynamic responses to TNF-␣ infusion in TNF␣R1 KO and TNF␣R2 KO mice. Percent changes in the hemodynamic responses (MAP, RVR, RBF, and GFR) to TNF-␣ administration in TNF␣R1 KO and TNF␣R2 KO, as well as WT, mice are shown in Figs. 1 and 2. As reported previously (32) , administration of human recombinant TNF-␣ (0.3 ng·min Ϫ1 ·g Ϫ1 iv) in WT mice did not alter MAP (from 98 Ϯ 1.6 to 98 Ϯ 1.8 mmHg, n ϭ 6). However, small, but statistically significant, decreases in MAP in response to human TNF-␣ administration were observed in TNF␣R1 KO (from 85 Ϯ 6.0 to 79 Ϯ 5.7 mmHg, P Ͻ 0.003, n ϭ 5) and TNF␣R2 KO (from 94 Ϯ 4.2 to 85 Ϯ 2.9 mmHg, P Ͻ 0.05, n ϭ 6) mice (Fig. 1A) . The responses to murine TNF-␣ in TNF␣R1 KO mice (from 87 Ϯ 6.2 to 84 Ϯ 5.3 mmHg, P Ͻ 0.05, n ϭ 5) are qualitatively similar to the responses to human TNF-␣. In WT mice (n ϭ 6), human TNF-␣ administration caused an increase in RVR (from 10.7 Ϯ 1.4 to 13.6 Ϯ 1.9 mmHg·ml , P Ͻ 0.05) in response to human TNF-␣ were observed in these WT mice (Fig. 2) . These responses were similar to those reported earlier from our laboratory (32) . In TNF␣R1 KO mice, these hemodynamic responses to human TNF-␣ were prevented and, in fact, reversed. Contrary to the responses in WT mice, human TNF-␣ caused a decrease in RVR (from 11.1 Ϯ 1.3 to 8.2 Ϯ 2.2 mmHg·ml Ϫ1 ·min·g Ϫ1 , P Ͻ 0.05; Fig. 1B ), an increase in RBF (from 8.1 Ϯ 0.9 to 10.1 Ϯ 1.0 ml·min Ϫ1 ·g Ϫ1 , P ϭ 0.055; Fig. 2A) , and no appreciable change in GFR [from 1.38 Ϯ 0.17 to 1.31 Ϯ 0.17 ml·min Ϫ1 ·g Ϫ1 , P ϭ not signficant (NS); Fig. 2B ] in these TNF␣R1 KO mice (n ϭ 5). In the TNF␣R1 KO group, responses to infusion of murine TNF-␣ were qualitatively similar to responses to infusion of human TNF-␣. RVR decreased (from 15.1 Ϯ 1.9 to 13.4 Ϯ 1.6 mmHg·ml Ϫ1 ·min·g Ϫ1 , P Ͻ 0.01), RBF increased (from 6.0 Ϯ 0.9 to 6.6 Ϯ 0.8 ml·min Ϫ1 ·g
Ϫ1
, P Ͻ 0.001), and GFR did not change appreciably (from 1.08 Ϯ 0.15 to 1.01 Ϯ 0.11 ml·min Ϫ1 ·g
, P ϭ NS) in response to murine TNF-␣ in TNF␣R1 KO mice. The changes in RVR and RBF were quantitatively somewhat larger in response to human than murine TNF-␣ (Ϫ24 Ϯ 6 vs. Ϫ9 Ϯ 2% for RVR and 28 Ϯ 11 vs. 11 Ϯ 2% for RBF) in TNF␣R1 KO mice. In TNF␣R2 KO mice (n ϭ 6), the changes in renal hemodynamic parameters in response to human TNF-␣ were comparable to those observed in WT mice (Figs. 1 and 2) . TNF-␣ administration caused decreases in RBF (from 6.5 Ϯ 0.4 to 5.3 Ϯ 0.6 ml·min Ϫ1 ·g Ϫ1 , 0.05 Ͼ P Ͼ 0.1) and GFR (from 0.67 Ϯ , P Ͻ 0.05; Fig. 4A ) and FE Na (from 0.6 Ϯ 0.4 to 2.3 Ϯ 0.4%, P Ͻ 0.001; Fig. 4B ) in response to human TNF-␣ were also observed in WT mice. These responses were similar to those reported earlier from our laboratory (32) . These diuretic and natriuretic responses to human TNF-␣ administration were absent in TNF␣R1 KO mice (Figs. 3  and 4) . The changes during human TNF-␣ administration in these TNF␣R1 KO mice (n ϭ 5) were from 4. , P ϭ NS; Fig. 3B ). Immunohistochemical analysis of TNF␣R1 and TNF␣R2 in renal tissues. TNF␣R1 and TNF␣R2 immunoreactivity and densitometric analysis in renal tissues are illustrated in Fig. 5 . Kidney slices from the WT mice show that TNF␣R1 was located in proximal tubules and collecting duct cells (Fig. 5A) , as well as endothelial and smooth muscle cells of the renal vasculature (Fig. 5B) . TNF␣R2 immunostaining was also observed mostly in proximal and collecting duct cells, but only in the renal vascular endothelium (Fig. 5, E-G) . Immunostaining for TNF␣R2 and TNF␣R1 was also performed in TNF␣R1 KO and TNF␣R2 KO mice, respectively. Mean data from the densitometric analysis of the intensity of immunoreactivity of TNF␣R1 and TNF␣R2 in these kidney sections are illustrated Fig. 5, D and H, respectively. TNF␣R1 immunoreactivity was higher (100 Ϯ 3 vs. 128 Ϯ 6% change in intensity, P Ͻ 0.01) in TNF␣R2 KO than WT mice (Fig. 5D) . Similarly, TNF␣R2 immunoreactivity was also higher (100 Ϯ 7 vs. 143 Ϯ 6% change in intensity, P Ͻ 0.002) in TNF␣R1 KO than WT mice (Fig. 5H) .
DISCUSSION
This present investigation describes the renal functional phenotypes in mice that are lacking one of the two known TNF-␣ receptors, type 1 (TNF␣R1 KO) or type 2 (TNF␣R2 KO). In the anesthetized condition, MAP was slightly, but significantly, lower in TNF␣R1 KO, but not TNF␣R2 KO, mice than in genetic background WT (C56BL/6) mice. Renal hemodynamic parameters (RBF, RVR, and GFR) are similar in TNF␣R1 KO mice but significantly lower in TNF␣R2 KO than WT mice. However, V and U Na V were lower in TNF␣R1 KO than TNF␣R2 KO or WT mice, which could be due to low basal MAP in TNF␣R1 KO mice. On the other hand, TNF␣R2 seems to play a more regulatory role in maintaining the basal levels of RBF, RVR, and GFR than V and U Na V, as the basal renal hemodynamic parameters were significantly lower in TNF␣R2 KO than WT mice. Although it was reported earlier from the experiments with human kidney tissues (1) that TNF␣R2 was mainly expressed in renal tubules, the present immunohistochemical analysis in mouse kidneys (Fig. 5B) indicates that this receptor is also located in the vascular endothelium, along with tubular epithelial cells. These immunohistochemical data in the present study show that a deficiency in TNF␣R1 leads to upregulation of TNF␣R2 in the renal tissues, and vice versa, which indicates a potential interaction of these receptors in regulating TNF-␣-induced responses in the kidney. An upregulation of TNF␣R1 in TNF␣R2 KO mice may have resulted in enhanced or unopposed effects of TNF-␣ on TNF␣R1 in the absence of TNF␣R2 that caused these reductions in the basal level of renal hemodynamic parameters in these TNF␣R2 KO mice. As it was reported that TNF-␣ inhibits renin gene expression and its production in the kidney (36) , it is also possible that an alteration in renin secretion rate might have influenced the basal hemodynamic values in TNF␣R2 KO mice, although the exact receptor type involved in the mechanism of renin inhibition by TNF-␣ has not been characterized. Although we did not measure the renin secretion level in these KO mice, the present findings may indicate that TNF␣R2 is involved in mediating TNF-induced inhibition of renin secretion in the kidney; such involvement may indicate that this receptor has a role in the general protective function of TNF-␣, as suggested earlier (12, 35) .
Chen et al. (7) reported that basal MAP in conscious TNF␣R1 KO mice was not significantly different from that in WT mice. However, the results of the present study, which was conducted in anesthetized mice, demonstrate that basal MAP was lower in TNF␣R1 KO than WT mice. This apparent discrepancy between the results from our study and the results reported by Chen et al. could be due to difference in the experimental preparations, as anesthetic agents can influence the regulatory function of cytokines and their receptors in maintaining generalized vascular tone (23, 34) . In the present study, we also observed that TNF-␣ at 0.3 ng·kg Ϫ1 ·min
Ϫ1
caused small, but statistically significant, reductions in MAP in TNF␣R1 KO and TNF␣R2 KO mice, although it caused no significant change in MAP in WT mice. In our earlier study (32) , we observed that TNF-␣ at Ͼ0.3 ng·kg Ϫ1 ·min Ϫ1 also resulted in decreases in MAP in WT mice that might be related to direct cardiac effect of TNF-␣, leading to the development of systolic dysfunction (33) . In the present study, slight decreases in MAP in response to TNF-␣ in TNF␣R1 KO and TNF␣R2 KO mice could also be related to such a dosedependent direct cardiac effect of TNF-␣.
Similar to the findings in our earlier study (32) , human recombinant TNF-␣ administration in WT mice in the present study also resulted in an increase in RVR and decreases in RBF and GFR. This form of human recombinant TNF-␣ was widely used in other earlier in vivo studies (7, 29, 32, 33) conducted in mice. The specificity of human TNF-␣ action in the mice was demonstrated in our earlier study (32) . The renal responses to systemic infusion of TNF-␣ were completely inhibited in mice pretreated with the TNF-␣ blocker etanercept (32) . In the present study, these renal vasoconstrictor and hypofiltrating effects of TNF-␣ were absent in TNF␣R1 KO mice. Rather, RBF increased and RVR decreased in response to human and murine TNF-␣ administration in TNF␣R1 KO mice. As human and murine TNF-␣ resulted in qualitatively similar responses in TNF␣R1 KO mice in the present study, it can be concluded that activation of TNF␣R2 in the absence of TNF␣R1 in the mouse could have resulted in the renal vasodilator action in response to TNF-␣.
Although mouse TNF␣R1 and TNF␣R2 are 64% and 62% identical to their human counterparts, it was also suggested that human TNF-␣ may not bind effectively to the mouse TNF␣R2 (28) . Such species specificity of TNF-␣ action was suggested from the findings in an in vitro study (28) that used a competitive binding assay of human and murine TNF-␣ in a human cell line (TSA 201) transfected with murine TNF␣R1 and TNF␣R2. However, it was also shown in the same study (28) that human TNF-␣ was able to compete for at least ϳ40% of the endogenous TNF␣R2 located in some mouse cell lines (particularly the L-M cell line), indicating some variability of human TNF-␣ action on mouse TNF␣R2. Such variable species preference between human and murine TNF-␣ was also reported in studies using in vitro and in vivo experiments (24) . In the present in vivo study, it has also been demonstrated that human and murine TNF-␣ caused decreases in RVR and increases in RBF, presumably acting via TNF␣R2 in these TNF␣R1 KO mice. However, these changes in RVR and RBF are quantitatively larger with human than with murine TNF-␣, indicating a degree of species preference of the recombinant forms of this cytokine, as reported previously (24) .
An enhancement of NO bioactivity could be linked to the renal vasodilator response to TNF-␣ in TNF␣R1 KO mice, as TNF-␣ infusion has been demonstrated to cause an increase in RBF in mice pretreated with tempol (32) . The renal vasoconstrictor action of TNF-␣ is mediated primarily by O 2 Ϫ production and, as such, reduces the bioactivity of NO, as described in our earlier study (32) . However, the present finding that TNF-␣ failed to cause a vasoconstrictor response in TNF␣R1 KO mice suggests that TNF␣R1 may be responsible for induction of O 2 Ϫ production. It was reported that TNF-␣ could upregulate expression of Nox2 and Nox4 subunits of NADPH oxidase in the renal tissues and could increase O 2 Ϫ production (29, 32, 33) . Also, endothelin-1 could be involved in mediating the renal responses to TNF-␣ administration, as other studies demonstrated a possible link between TNF-␣ and endothelin-1 release (8, 26) . Additional experiments are required to examine this issue. TNF-␣ was also known to induce enhancement in tissue expression of endothelial NO synthase, as well as increases in NO production (29, 33) .
Although not yet known definitively, this induction of NO by TNF-␣ could be mediated by the activation of TNF␣R2 as part of its protective role in the kidney (12, 35) . As the present findings demonstrate that TNF␣R2 is located only in the vascular endothelium, but not in vascular smooth muscle cells, and that this receptor is upregulated in TNF␣R1 KO mice, it is reasonable to assume that the activation of TNF␣R2 induces NO production that is involved in mediating the vasodilator response to TNF-␣ in the absence of TNF␣R1 in those mice. On the other hand, the hemodynamic responses to TNF-␣ administration in TNF␣R2 KO mice were comparable to those in WT mice, indicating that the renal vasoconstrictor response to TNF-␣ was largely dependent on the activation of TNF␣R1.
In the present study, TNF-␣ administration resulted in increases in V and U Na V in WT mice, as reported earlier (32) . These diuretic and natriuretic responses to TNF-␣ were completely absent in TNF␣R1 KO, but not TNF␣R2 KO, mice. The responses to TNF-␣ in TNF␣R2 KO mice were qualitatively identical to those in WT mice. It was reported in previous in vitro studies that TNF-␣ exerts direct inhibitory action on Na (25) , and epithelial sodium channel activity (2) in the renal tubule. As shown in our earlier experiments (27, 32) , this diuretic and natriuretic response to TNF-␣ was prevented in mice pretreated with amiloride, indicating that this natriuretic response was mediated by inhibitory action of TNF-␣ on tubular epithelial sodium channel activity. The finding in the present study that TNF␣R1 is localized in the collecting ducts also supports this action of TNF-␣. Moreover, TNF␣R1 is also localized in the proximal tubular cells. Collectively, these results indicate that the natriuretic response to TNF-␣ is mediated by its activation of TNF␣R1 in the renal tubules.
The findings in the present study clearly emphasize an interactive role for these TNF-␣ receptors in regulating the renal hemodynamic and tubular transport in conditions of acute episodes of inflammatory insult that are marked with an increase in the plasma level of TNF-␣. Although TNF␣R1 and TNF␣R2 seem to play opposing roles in renal vascular function, it is not clear how these receptors interact with each other in regulating tubular transport function. As it was observed in the present study that the sodium excretion response to TNF-␣ infusion remains unaltered in TNF␣R2 KO mice, it seems that there is no role or a minimal role of TNF␣R2 in this natriuretic response, although this receptor is abundantly located in proximal and distal tubular segments. The exact functional role of TNF␣R2 in regulating renal tubular function, which may be important in chronic inflammatory conditions, is not clearly understood. More comprehensive studies using in vitro and in vivo models are required to examine further the mechanistic insight or in-depth evaluation of the interactions of TNF-␣ and its receptors in regulating renal tubular function.
The physiological or pathophysiological significance of these acute renal responses to TNF-␣ is not clearly understood. Although an involvement of TNF-␣ has been implicated recently in the development of salt sensitivity (10, 11, 17, 33) and hypertension (16, 18, 38) , the present finding that TNF-␣ administration induces the diuretic and natriuretic responses does not support a direct role of TNF-␣ in the mediation of salt-sensitive hypertension. However, it was demonstrated that ANG II infusion failed to induce hypertensive responses in mice lacking the genes for TNF-␣ (33) or T lymphocytes (18) that are activated to increase the production of TNF-␣ in response to ANG II administration. Future studies to delineate the differences between acute and chronic renal effects of TNF-␣ and other proinflammatory molecules would provide more in-depth understanding of the pathophysiology of the disease conditions that are marked with inflammatory processes due to many biological and environmental threats.
In conclusion, the present investigation describes the localizations of TNF␣R1 and TNF␣R2 in the mouse kidney and evaluates the renal functional phenotype in mice that are lacking either of these receptors. These data demonstrate that activation of TNF␣R1, not TNF␣R2, is mainly involved in mediating the acute renal vasoconstrictor and natriuretic actions of TNF-␣.
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